Hologic Inc (STU:HO1)
€ 72 -4.5 (-5.88%) Market Cap: 16.83 Bil Enterprise Value: 17.02 Bil PE Ratio: 23.66 PB Ratio: 3.57 GF Score: 87/100

Hologic Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 23, 2022 / 06:15PM GMT
Release Date Price: €62.72 (+1.29%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Well, great. Thank you for joining us at the Citi Healthcare Conference here. I'm Patrick Donnelly, the tools and diagnostics analyst with Citi. Excited to have Karleen Oberton with us from Hologic. She's the CFO. And Karleen, I know -- maybe we can give some introductory remarks, and then we can dive right into Q&A. And if investors have any questions, feel free to e-mail them over to me, and I will try to get them asked.

And Karleen, I'll turn it over to you.

Karleen M. Oberton
Hologic, Inc. - CFO

Great. Thanks, Patrick, and it's a pleasure to be here today. So for those who may be not so familiar with the Hologic story, we are a medical technology company uniquely focused in women's health care. We have clinically differentiated market-leading products in each of our divisions. We are organized within 3 divisions: our Diagnostics, Breast Health and Surgical. And over 85% of our revenue today is recurring in nature between disposable revenues and service revenues. And

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot